The orthopedic device market is expected to grow at an annual rate of 4.9 percent from 2013 to 2019 and reach a value of $41.2 billion, according to a Transparency Market Research report.
Spinal Tech
Mazor Robotics will report its fourth quarter and year-end financial results before U.S. markets open on Tuesday, Feb. 25.
Isador Lieberman, MD, of the Texas Back Institute in Plano has performed 250 spine surgery cases using technology from Mazor Robotics, including the Renaissance robotic surgical system.
The global bone graft and substitutes market is expected to increase from $2.1 billion to $2.7 billion by 2020, a compound annual growth rate of 3.8 percent.
Carlsbad, Calif.-based Aurora Spine sold its 100th ZIP Ultra MIS Interspinous Fusion system in Italy, just four months after the first Italian surgery with the device took place.
The Kiva VCF Treatment System by Santa Clara, Calif.-based Benvenue Medical has received FDA 510(k) clearance for the treatment of spinal fractures.
Here are seven key notes on major spine and orthopedic device companies.
Here are four spine and orthopedic device companies that recently expanded through acquisitions, new market presence or the construction of new facilities.
Paris and San Francisco-based SpineGuard has entered into a standby equity facility with Société Générale, under which Société Générale has committed to purchase newly created shares at any time during an agreed upon 36-month period.
Leesburg, Va.-based K2M submitted an S-1 draft resignation statement to the U.S. Securities and Exchange Commission for its proposed initial public offering.
